Monday, March 16, 2026 9:41:29 AM
$SYIN post this morning on X:
The CEO of FacialDx, Doug Benoit and I in Australia this week. We met with the team at Resonance Health to begin planning the mental health clinical trial. Exciting progress as we move toward validation.
The CEO of FacialDx, Doug Benoit and I in Australia this week. We met with the team at Resonance Health to begin planning the mental health clinical trial. Exciting progress as we move toward validation.
Recent SYIN News
- Synbio International Inc. Expands its Board of Directors and Strengthens its Clinical Leadership with the Appointment of Dr. Nick Vatakis • GlobeNewswire Inc. • 10/22/2025 01:00:00 PM
- Synbio International Inc. Strengthens Strategic Alliance with FacialDx Inc. through Share Purchase and Warrant Agreements • GlobeNewswire Inc. • 10/08/2025 01:00:00 PM
- Synbio International Inc. Expands Board and Strengthens Leadership with Appointment of Chief Financial Officer Ms. Desiree Cain, CPA, MBA • GlobeNewswire Inc. • 10/02/2025 02:05:59 PM
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 09/04/2025 06:00:03 PM
